Category: News This Week

  • New Checks on U.K. Track-and-Trace Codes

    New Checks on U.K. Track-and-Trace Codes

    Photo: vchalup

    Her Majesty’s Revenue & Customs (HMRC) has introduced new checks on the codes that are given to tobacco retailers to ensure that they are registered properly for the U.K. track-and-trace system, reports Talking Retail.

    Businesses throughout the tobacco supply chain have an economic operator ID code for their business and a facility ID code for each site. Over the next eight weeks, any codes that are not recognized by the track-and-trace system will generate a warning, allowing businesses time to investigate by logging any issues with the ID Issuer website.

    After June 27, messages containing codes that fail the new checks will generate an error message. Retailers that receive an error message must take action to correct the error before continuing to move tobacco products through the supply chain.

    “We have worked extensively with HMRC to support retailers with the implementation of the tobacco track-and-trace system since its introduction in 2019, and we hope that this is another step toward only legitimate businesses being involved in the tobacco supply chain,” ACS’ chief executive, James Lowman, was quoted as saying.

    “We welcome the eight-week grace period, which should give businesses time to investigate any issues with their codes.”

  • 22nd Century Installs Nicotine Equipment

    22nd Century Installs Nicotine Equipment

    Photo: Nitiphol

    22nd Century Group is advancing and expanding the capabilities of the laboratory at its cigarette manufacturing facility in Mocksville, North Carolina, USA, for testing of its VLN reduced nicotine content tobacco and cigarettes. The company estimates that its cost per VLN sample will improve by more than 90 percent, and the lead time for key data will take less than a day compared to using a third-party testing service that can take weeks.

    “This is an important investment and milestone for 22nd Century, as it is imperative to the launch of VLN and the future of the organization that we have the ability to rapidly conduct high-precision analysis of our own products at higher testing volumes,” says James A. Mish, CEO of 22nd Century Group, in a press note.

    22nd Century now has the same lab testing equipment and capabilities as outside facilities. The company is also working toward receiving ISO/IEC 17025 accreditation, which grants international recognition of an organization’s commitment to quality, competency and reliable results. This accreditation demonstrates to customers and industry that 22nd Century has the technical competence to provide reliable and accurate test results even at the lowest nicotine levels.

    Earlier this year, 22nd Century announced that it significantly expanded its tobacco growing program to support the anticipated demand for its VLN cigarettes.

  • Uganda Promoting Local Cigarette Production

    Uganda Promoting Local Cigarette Production

    Photo: Taco Tuinstra

    Uganda’s Parliament has passed a bill scrapping taxation on processed tobacco and restricting it to unprocessed leaf for export, the Parliament’s website reported. The measure is meant to promote local value addition and improve revenue.

    According to finance committee chairman Henry Musasizi, levying tax on both processed and unprocessed leaf will undermine the efforts of companies that have set up plants to process it locally and justify the efforts of those companies that moved out of Uganda.

    “We shall also experience an increase in contraband and smuggling of cigarettes into Uganda, loss of jobs to Ugandans working in the processing plants and stifle agri-industrialization,” Musasizi said.

    Representative Syda Bbumba said that an export levy on unprocessed tobacco should be charged to discourage its exportation and encourage local processing of the product.

    “Tobacco growing is already exploitive on our farmers and, therefore, we should encourage value addition. We also need to increase the levy on imported cigarettes to encourage those processing tobacco to manufacture it locally,” she said.

    Representative Solomon Silwany said that the government should focus on the unprocessed leaf and tax it at a rate of $1 per kg. “We have local companies that are struggling to process and employing people; this should be our opportunity to support and encourage them to produce cigarettes as a finished product,” he noted.

    The Minister of State for Finance David Bahati, however, said that the local companies should make sure the tobacco leaf is dried and manufactured into cigarettes.

    “We do not want to be confused by these people simply drying the tobacco leaf to skip taxes instead of the more worthwhile process of manufacturing cigarettes,” he said.

  • Paul Hardman to Lead BNS Scientific Affairs

    Paul Hardman to Lead BNS Scientific Affairs

    Broughton Nicotine Services (BNS) has appointed Paul Hardman as head of scientific affairs, the latest in a series of senior level appointments, as it continues to expand its services.

    The business, which has helped electronic nicotine device companies bring noncombustible products to market, is currently expanding its full-service regulatory consultancy into modern oral nicotine products, heated-tobacco products and cannabidiol products.

    A scientist with extensive experience in inhaled product development across pharmaceutical and consumer products, Hardman will have the task of growing the scientific affairs team to enable the business to grow and offer a premium consultancy experience for clients in the industry.

    “We’re delighted to have welcomed someone of his caliber into this new role,” said Nveed Chaudhary, chief regulatory officer of Broughton Nicotine Services. “His addition to the Broughton team will strengthen the business further as we look to expand our full-service regulatory consultancy. Paul will take responsibility for delivering product development and optimization activities, drawing on his years of industry leadership and experience.”

    Prior to joining Broughton, Hardman was scientific lead with Imperial Brands, where he was responsible for designing the testing strategy for the chemistry of inhaled and oral next-generation nicotine products, from assessing a variety of prototypes at the early stages of development through to characterization of products for submission through the U.S. premarket tobacco product application process.

    He began his career working at a specialist pharmaceutical company where he gained experience of dry powder and metered dose inhaler development, including for the treatment of local lung conditions and systemic absorption. Hardman also has experience leading the quality control department in a multinational pharmaceutical company involved in the production of generic nicotine lozenges.

    Paul’s addition to the Broughton team will strengthen the business further as we look to expand our full-service regulatory consultancy.

    “I am passionate about the opportunity to work with multiple clients and really get to the heart of their products so that Broughton Nicotine Services can best serve these businesses by championing those points in their regulatory submissions,” said Hardman.  

    “My role will involve growing the team to enable us to deliver a highly effective offering as Broughton moves into new areas, and I am eager to build on the success the business has already achieved.”

  • Regulatory Environment ‘Manageable’ in U.S.

    Regulatory Environment ‘Manageable’ in U.S.

    Photo: Miriam Doerr | Dreamstime.com

    Tobacco companies will have plenty of time to adopt to a U.S. menthol ban, if one is ever implemented, according to financial analysts quoted by the Winston-Salem Journal.

    On April 29, the U.S. Food and Drug Administration announced its intention to ban the flavoring in combustible cigarettes and cigars. The agency expects to unveil product standards in 2022. The FDA would then have to submit its proposal, consider comments and prepare a final proposal, which could take multiple years, according to RBC Capital Markets analyst Nik Modi.

    That’s not counting expected multiple rounds of lawsuits, some of which could advance to the U.S. Supreme Court to resolve. The FDA is required to base its rulemaking on science, and the tobacco industry is likely to challenge the scientific basis for a menthol ban.

    “The published science does not support regulating menthol cigarettes differently from nonmenthol … nor does it support that menthol cigarettes adversely affect initiation, dependence or cessation,” Reynolds American said on April 29.

    We consider the U.S. regulatory environment to be manageable. We expect any menthol ban, if one comes, to be years and years away.

    Goldman Sachs analyst Bonnie Herzog noted that the FDA didn’t also reveal plans to dramatically reduce the nicotine levels in cigarettes during the menthol ban announcement.

    “It is not surprising to us given less urgency around this issue, i.e., no court-imposed deadline, but we still think there’s a possibility that something could be announced in the coming weeks/months ahead … as the critical premarket tobacco [product] application process for e-vapor unfolds,” Herzog was quoted as saying.

    “Both issues entail a complex and lengthy process that, based on precedent, will likely take several years to be successfully implemented, if at all.”

    In 2018, the agency officially announced its intention to require cigarette manufacturers to lower the nicotine levels in their products to nonaddictive levels, but the FDA has not yet acted. In the weeks prior the menthol announcement, speculating mounted that the agency would soon act on its reduced-nicotine plan.

    Piper Sandler analyst Michael Lavery said, “we consider the U.S. regulatory environment to be manageable. We expect any menthol ban, if one comes, to be years and years away.”

  • Activist Groups Plead Against Menthol Ban

    Activist Groups Plead Against Menthol Ban

    Photo: Bacho12345 | Dreamstime.com

    Americans for Tax Reform has released a letter signed by 36 organizations representing millions of taxpayers and consumers throughout the United States urging the Food and Drug Administration to reject a proposed ban on menthol cigarettes.

    The letter notes the social impact of criminalizing an activity undertaken by over 18 million Americans, primarily from minority communities, asserting, “If this proposal were to be enacted, it is inevitable that it would lead to further confrontations between individuals and law enforcement and break down trust even further. In addition, by diverting law enforcement resources to preventing the sale of menthol cigarettes, this policy will reduce the resources available for the prevention and solving of property and violent crimes.”

    The letter continues, “We further draw your attention to the fact that any comprehensive analysis of the data from jurisdictions where menthol products have been banned demonstrates that, while the majority of users switch to nonmenthol cigarettes, over 20 percent of menthol smokers moved to purchasing illicit products through the black market. Not only does this put all parties involved at risk of police involvement, the illicit tobacco market has increasingly been run by sophisticated international criminal syndicates, often with links to sex trafficking, money laundering and even, increasingly, terrorism.”

    For these reasons, as the letter noted, the U.S. State Department has explicitly called tobacco smuggling, “a threat to national security.”

    The letter also recognized the importance of promoting harm reduction over prohibition, writing, “If the FDA wishes to reduce smoking rates, the best way of doing this is not through bans but rather embracing life-saving new technologies to help smokers quit.

    “The science is now overwhelming that the most effective way for smokers to quit is through the use of noncombustible reduced-risk tobacco alternatives, ranging from vapor and “heat-not-burn” devices to oral nicotine-delivery systems or moist loose tobacco (which the FDA already allows to be marketed as reducing the cancer risk for persons who make the switch).”

    If the FDA wishes to reduce smoking rates, the best way of doing this is not through bans but rather embracing life-saving new technologies to help smokers quit.

    The letter concluded by urging the FDA to “engage in evidence-based policymaking and embrace new technologies and alternative nicotine-delivery systems that have been proven will be able to save millions of American lives.”

    Earlier, the American Civil Liberties Union also sent a letter, signed by 27 civil liberty and racial justice organizations, expressing its concern about the impact on minorities of a menthol ban.

    “At this pivotal moment, as the public demands an end to police violence erupting from minor offenses, we call on the Biden administration to rethink its approach and employ harm reduction strategies over a ban that will lead to criminalization,” said Aamra Ahmad, senior legislative counsel for the ACLU.

    “As we approach the one-year anniversary of the murder of George Floyd—only a few years removed from the killing of Eric Garner, a Black man killed by NYPD for selling loose, untaxed cigarettes—the racially disparate impact of the criminal legal system has captured the nation’s attention. It is now clear that policies that amount to prohibition have serious racial justice implications.”

    Anti-tobacco activist Stanton Glantz dismissed the argument that getting rid of menthol would lead to more police violence against African Americans as baseless. He accused the ACLU of advocating tobacco positions after taking industry money.

    “The ACLU has been carrying the tobacco industry’s water for decades,” Glantz wrote on his blog. The ACLU has opposed clean indoor air laws since shortly after I first got involved in trying to pass them in 1978, arguing against the evidence that secondhand smoke was dangerous and that there was a right to smoke.

    “Why? Thanks to a series of reports in the early 1990s by legendary Washington Post investigative reporter Morton Mintz (Nieman Reports, Advocacy Institute), we now know that the ACLU secretly accepted millions of dollars from the tobacco industry,” he added.

  • Think Tank Urges Easing of ENDS Restrictions

    Think Tank Urges Easing of ENDS Restrictions

    Photo: lezinav

    The U.K. Vaping Industry Association (UKVIA) has welcomed the Adam Smith Institute’s report published today. “The Golden Opportunity—How Global Britain can lead on tobacco harm reduction and save millions of lives” warns that the U.K. is on course to miss its “smoke-free by 2030” target unless regulations around alternative products are relaxed.

    The UKVIA has consistently called for the U.K. to make the most of the opportunities presented by leaving the European Union, which are now available to the vaping sector. This includes removing unnecessary regulations, which the association believes are often a barrier to harm reduction and tackling misinformation about e-cigarettes. The UKVIA included these matters in its recent submission to the government’s consultation on the Tobacco and Related Products Regulations (TRPR) published in March.

    The U.K. has taken a world-leading role in harm reduction in this area, and it should continue to do so, according to the UKVIA. To achieve smoke-free status, however, more work still needs to be done. The report points out that despite huge take up in smoking cessation products in recent years, there are still 7 million smokers in the U.K., which equates to 14.1 percent of adults. There is a concern within the sector that current low rates for smoking could be reversed by an increase in social smoking because of recent Covid-19 lockdowns.

    The Adam Smith Institute report, written by its head of programs, Daniel Pryor, also calls for “ineffectual warnings” on some vaping products to be replaced and argues that the U.K. should “robustly defend its approach to tobacco harm reduction” at the global Framework Convention on Tobacco Control’s COP9 and related World Health Organization meetings later this year.

    This report is welcome as it shows the opportunities which are now available for the U.K. vaping sector in terms of increasing smoking cessation and promoting harm reduction.

    Following the recent announcement of a trial of e-cigarette products taking place in five hospital A&E departments later this year, the sector anticipates an additional boost to the numbers of people switching to e-cigarettes and awaits the results of the trial with interest.

    “This report is welcome as it shows the opportunities which are now available for the U.K. vaping sector in terms of increasing smoking cessation and promoting harm reduction, which is why the UKVIA called for vape retail outlets to be classified as ‘essential retail’ throughout the recent lockdowns,” said UKVIA Director General John Dunne.

    “The Adam Smith Institute’s report builds on our own proposals, which we submitted to the government’s TRPR consultation. We support the report’s proposals on opposing ‘counterproductive regulations,’ which can harm efforts to get smokers to switch to safer alternatives.”

    “The UKVIA is already working with international partners ahead of the crucial COP9 summit later this year. We will continue to represent the sector as a whole and highlight the consensus opinions of U.K. public health bodies on the safety and efficacy of e-cigarettes to policymakers. We will continue to encourage the government to allow ‘Global Britain’ to use its newly independent position to encourage the World Health Organization to adopt a more reasonable approach with regards to reduced-risk products.”

  • Menthol Ban Would Hasten Volume Decline

    Menthol Ban Would Hasten Volume Decline

    Photo: Валерий Моисеев

    The U.S. Food and Drug Administration’s plan to ban menthol cigarettes and flavored cigars is credit negative for the tobacco industry and settlement asset-backed securities because, if enacted, the initiatives would accelerate cigarette volume declines and hurt profitability, according to Moody’s Investor Service.

    Tobacco companies that sell menthol cigarettes in the U.S. market would be negatively affected, although some existing smokers will likely migrate to nonmenthol cigarettes, thus limiting the negative impact of such measures on consumption.

    Given their strong financial metrics, tobacco companies would likely be able to absorb any decline in performance without a major deterioration in their credit metrics. Approximately 29 percent of cigarette sales in the U.S. are menthol flavored per Euromonitor.

    On April 29, the FDA said that it would work toward developing a regulation banning menthol cigarettes and flavored cigars within the next year. Moody’s expects tobacco companies would seek to strike down such a ban through the courts, so implementation could be years away. Any ban would need to be science-based or it would not withstand judicial review.

    The investor service estimates that U.S. cigarette volumes will decline between 3 percent and 5 percent over the next three years to five years excluding a menthol ban. However, it believes a menthol ban would likely accelerate that rate of decline to the low double-digit level. “We expect tobacco companies would be able to take pricing actions to initially offset this decline, but their ability to do so would diminish over time as cigarettes become less affordable,” Moody’s wrote in a note to investors.

    “We believe that banning menthol cigarettes, which represent around 29 percent of U.S. cigarette sales by volume, would also likely increase illicit trade, resulting in a loss of revenue for legal manufacturers as well as a loss of tax revenue for federal, state and local governments.”

    Among the companies with the most exposure are British American Tobacco (BAT) and Altria Group, according to Moody’s. Through its subsidiary, Reynolds American Inc., BAT generates approximately 20 percent to 25 percent of its operating profits from menthol cigarettes. Altria Group Inc. generates approximately 20 percent of its sales from menthol cigarettes.

    Given their strong financial metrics, tobacco companies would likely be able to absorb any decline in performance without a major deterioration in their credit metrics.

    BAT relies on the U.S. for about 45 percent of its operating profits, of which underlying menthol cigarette volumes account for around 50 percent. Moody’s estimates that Imperial Brands generates around 10 percent of its operating profits from sales of menthol cigarettes, based on a U.S. contribution to total profit of around 25 percent, of which underlying menthol cigarette volume accounts for 45 percent. Like Altria, BAT has alternative products, too, in the U.S. market, such as oral tobacco and vaping products, which could at least partly offer alternatives to menthol smokers.

    Altria would be impacted by a menthol ban given its large market share; however, several factors would mitigate this impact. Altria offers a suite of noncombustible alternative products, such as e-cigarettes (through its 35 percent investment in Juul) and oral tobacco, that smokers could potentially convert to should a menthol ban be implemented. Altria also sells the IQOS heat-not-burn device in the U.S. under a licensing agreement with Philip Morris International (PMI). The FDA has authorized IQOS as a modified-risk tobacco product, and IQOS could gain new users if menthol products are banned.

    Finally, Altria has strong financial metrics and could potentially shift its financial policy to offset a decline in operating performance, including decreasing its dividend payout or share repurchase activity.

    PMI has no direct exposure to the U.S. cigarette market and would not be negatively impacted by this ban, according to Moody’s.

    The FDA stated that it intends to start the process for advancing two tobacco product standards for menthol in cigarettes and all flavors in cigars with the aim to ban these products. The agency specifically seeks to reduce the number of new smokers, increase the likelihood that existing menthol smokers quit smoking and address health disparities among minority communities, where the FDA says usage of flavored cigarettes is high.

    We believe that banning menthol cigarettes, which represent around 29 percent of U.S. cigarette sales by volume, would also likely increase illicit trade, resulting in a loss of revenue for legal manufacturers as well as a loss of tax revenue for federal, state and local governments.

    Tobacco companies believe that the published science so far has not supported regulating menthol cigarettes differently from nonmenthol and that scientific evidence does not show a difference in health risks between menthol and nonmenthol cigarettes. The companies say that scientific evidence does not support that menthol cigarettes adversely affect initiation, dependence or cessation.

    Other markets have imposed similar bans, including Canada in 2017 and the European Union in 2020. Although the impact of such bans on overall cigarette consumption is still being evaluated, the rate of decline in the overall cigarette volumes sold by tobacco companies has not significantly changed so far.

    A ban on menthol cigarettes in the U.S. would also be credit negative for long-dated tobacco settlement bonds backed by the 1998 Master Settlement Agreement (MSA) payments. The performance of those ABS directly depends on annual U.S. cigarette volumes, and an accelerated volume decline will materially lower revenue to the bonds. Certain alternative tobacco products, such as the heated-tobacco units used with IQOS2, are included under the MSA as part of revenue to the ABS. But these alternative products are currently in their infancy in the U.S., and their sales will not offset the material decline in revenue should the FDA implement its menthol cigarette ban, according to Moody’s.

  • China Now Top Market for Cuban Cigars

    China Now Top Market for Cuban Cigars

    Photo: Timothy S. Donahue

    There is a new leader in the Cuban cigar market. During the Habanos World Days event today, Leopoldo Cintra Gonzalez, the commercial vice president for Habanos, made the announcement at a virtual press conference from Havana. “For the first time in our history, China has become our No. 1 market in the world,” he said.

    Spain was the previous market leader, and in 2019, China was No. 2. However, growth has accelerated in China; sales to that country increased by more than 50 percent over the past six years. Last year alone, China’s demand for Cuban cigars grew by 5 percent, according to Habanos. While China ranks No. 1, Europe is still the largest region for Cuban cigars. In 2020, 60 percent of Habanos sales came from Europe, according to Gonzalez.

    Spain has become the second most valuable market for Cuban cigars, followed by France, Germany and Switzerland to complete the top five markets worldwide. Asia has been the leading growth market for Habanos, according to Gonzalez. He said the region has grown more than 10 percent in the last year, even with the difficulties presented due to the Covid-19 pandemic.

    2020 has been a challenging year, not just for our business [but also] for humanity.”

    The positive outlook from China, however, was offset by a 4 percent drop in Habanos’ total revenues in 2020. The pandemic was said to be the main cause of the drop, with stores closing and the lack of tourism dollars in many nations, but Habanos still earned nearly $507 million in total sales for the year, according to Gonzalez.

    “2020 has been a challenging year, not just for our business [but also] for humanity,” said Gonzalez. “But if we analyze it in depth, we see that there are markets especially affected by the drop in tourism, such as Cuba.”

    To prevent the spread of Covid-19, Cuba temporarily closed its borders to tourists in March 2020. A reopening in November caused infections to surge, prompting authorities to reduce flights and tighten restrictions again.

    “If we discount the negative effect of this specific market, we would only be talking about a [cigar sales] drop in the 2 percent [region],” said Gonzalez.

    Gonzalez said that, overall, the future for Habanos was still bright, and the company expects to exceed 2019 sales in 2021. “We must highlight the good mix of launches and actions carried out during the year,” he said. “This year, a total of 19 products have reached the markets to satisfy all the needs of fans where novelties in the standard portfolio are mixed with highly successful and profitable specialties, confirming the high demand in the super premium segment.”

    The Habanos World Days event is going to be a new annual event for Habanos. During a Q&A session, Gonzalez told Tobacco Reporter that having an annual online event allows the global Cuban cigar community to learn about the company and experience all that the world of Habanos has to offer firsthand. —T.S.D.

  • Brazilian Leaf Exports up in 2021

    Brazilian Leaf Exports up in 2021

    Photo: Taco Tuinstra

    Brazil is likely to export significantly more leaf tobacco this year than it did in 2021, according to the Interstate Tobacco Industry Union, SindiTabaco, which expects tobacco export revenues to grow accordingly.

    A survey conducted for SindiTabaco by Deloitte shows that shipments should increase between 2.1 percent and 6 percent in volume and between 6.1 percent and 10 percent in value compared to 2020, when exports amounted to 514 million kg and $1.64 billion.

    From January to March 2021, exporters shipped 134 million kg of tobacco valued at $418 million, up 19 percent from the same period in 2020, according to the Ministry of Economy.

    “Brazil has managed to keep annual exports at approximately 500,000 tons, a fact that attests to stability in the global market even in the face of a pandemic and all its social and economic developments,” said Iro Shuenke, president of SindiTabaco, during a meeting with tobacco supply chain stakeholders on April 28.

    It is our expectation that Brazil will continue as leading global tobacco exporter, a position occupied by the country since 1993.

    The Brazilian tobacco growers’ association Afubra expects southern Brazil to produce 606.95 million kg of tobacco in an area of ​​273,356 hectares this year, according to a report relayed by Kohltrade. The number of tobacco-growing families declined by 6.02 percent to 137,618 this season.

    In 2020, tobacco accounted for 0.8 percent of Brazilian exports. In Rio Grande do Sul, which produces nearly half of Brazil’s tobacco crop, the product accounted for 9.5 percent of all exports.

    The main destinations for Brazilian tobacco in 2020 were the European Union, accounting for 41 percent of the country’s leaf exports; the Far East (24 percent); and Africa/the Middle East (11 percent).